A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis.
about
DNA-aptamer targeting vimentin for tumor therapy in vivo.Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry.Loss of pannexin 1 attenuates melanoma progression by reversion to a melanocytic phenotype.Nestin and vimentin colocalization affects the subcellular location of glucocorticoid receptor in cutaneous melanoma.Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.Proteomic analysis of proton beam irradiated human melanoma cellsMethylation status of insulin-like growth factor-binding protein 7 concurs with the malignance of oral tongue cancerVimentin in cancer and its potential as a molecular target for cancer therapy.Biomarkers as key contributors in treating malignant melanoma metastases.Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomasSlug expression during melanoma progressionEpigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasionMorph-X-Select: Morphology-based tissue aptamer selection for ovarian cancer biomarker discoveryMICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion.1,3-Bis(3,5-dichlorophenyl) urea compound 'COH-SR4' inhibits proliferation and activates apoptosis in melanoma.Development of DNA damage response signaling biomarkers using automated, quantitative image analysis.Circulating tumor cells in sarcomas: a brief review.Gambogenic acid induces cell growth inhibition, cell cycle arrest and metastasis inhibition in choroidal melanoma in a dose-dependent manner.Linneg Sca-1high CD49fhigh prostate cancer cells derived from the Hi-Myc mouse model are tumor-initiating cells with basal-epithelial characteristics and differentiation potential in vitro and in vivo.Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma.SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cellsAnti-metastatic study of liposome-encapsulated all trans retinoic acid (ATRA) in B16F10 melanoma cells-implanted C57BL/6 mice.Synovial Sarcoma Microvesicles Harbor the SYT-SSX Fusion Gene Transcript: Comparison of Different Methods of Detection and Implications in Biomarker Research.Down-regulation of pseudogene Vimentin 2p is associated with poor outcome in de novo acute myeloid leukemia.Relationship of intratumoural protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma.Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.Effect of long non-coding RNA PVT1 on cell proliferation and migration in melanoma.Specific cytotoxic T-cell immune responses against autoantigens recognized by chronic lymphocytic leukaemia cells.Transplantable Melanomas in Hamsters and Gerbils as Models for Human Melanoma. Sensitization in Melanoma Radiotherapy-From Animal Models to Clinical Trials.miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC.Expression of mesenchymal markers vimentin and fibronectin: the clinical significance in esophageal squamous cell carcinoma.Vimentin Diversity in Health and Disease
P2860
Q30415521-4352DF2C-70E1-44C8-9B10-7FD0ED3B2F04Q33626833-D999B5CC-01F1-4804-AC4A-36E578403496Q34285486-97C341D9-75A9-481A-BFAE-934DDEF84FECQ34448594-2516E2F3-7E26-4C0B-95DB-70C4EC4C2E49Q34694101-96303C1D-6525-4BC9-AA78-B69AB0D5906BQ35083440-4DDFDE45-AF4B-4E4D-99C1-D441F6E49BEEQ35164959-B050F175-F8B2-470A-89C0-F216904FDD53Q35182104-3701CD0D-6CE1-4154-816A-582F01D5847CQ35550888-BE14A30E-2495-4E80-AE41-F35AC8B28E79Q35845352-A225C63C-4792-454D-B7AD-716047AFFB49Q36044631-4FB479DE-0A33-4EE4-BC38-BE28292A6C5BQ36187865-0507A67C-ADFE-4241-8086-A3809407BA61Q36190984-5DF781F9-CF98-4B0F-BBE7-3197B32EA0CFQ36738978-E42CC499-FA25-4685-BF24-4D6910E83B88Q37106124-1D6F8FD9-BFC5-4475-83C8-0B4A07A46F2AQ37604397-6BDC44C1-5CA9-42A8-8177-CCD2EB6E1DD4Q38285795-C3FE09E6-326E-42A2-9C9A-085592E120C1Q38701719-41251D49-D5FC-4261-8C68-45D303E612F9Q38791434-D06A6C2F-5650-463A-89EC-7B78504FB0D9Q38854848-0E237E20-FB4F-43EA-A1D7-A4FB0BF730F2Q38885517-15D54271-4748-45E9-9E1E-BE9AC0426868Q38948290-AD02FCC0-5720-4441-9185-5180D13F7CA6Q39652878-6F381563-66B7-4EC5-AC50-4A540D866094Q40371904-3DC5125F-6261-4354-A121-1F089542A46CQ42183852-6C9513D9-33AA-42C3-9AE1-4C4EC0BF9F49Q48487663-44068808-3275-44A3-9018-1D5D4A7212E4Q49500400-C97D95B2-8CC8-43DE-BA37-A371E3DABF63Q50654687-88812E8C-9DE8-4F98-9DFB-DABF241C68A7Q52929781-6595FAFF-B695-466A-8DDC-AE97B88C98FBQ52958669-FE3EA941-EEF6-4FF0-8982-342B4702CFD7Q54307724-44FC241B-2D76-4E3B-A69F-A92DF349C375Q58702541-C0802C01-BD12-4209-97EA-B58A9C1EDE40
P2860
A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
A novel function for vimentin: ...... anoma hematogenous metastasis.
@ast
A novel function for vimentin: ...... anoma hematogenous metastasis.
@en
type
label
A novel function for vimentin: ...... anoma hematogenous metastasis.
@ast
A novel function for vimentin: ...... anoma hematogenous metastasis.
@en
prefLabel
A novel function for vimentin: ...... anoma hematogenous metastasis.
@ast
A novel function for vimentin: ...... anoma hematogenous metastasis.
@en
P2093
P2860
P356
P1476
A novel function for vimentin: ...... anoma hematogenous metastasis.
@en
P2093
Baocun Sun
Baogang Zhang
Xinchao Ban
Xiulan Zhao
Zhiyong Liu
P2860
P2888
P356
10.1186/1756-9966-29-109
P577
2010-08-11T00:00:00Z
P5875
P6179
1006745664